These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11766485)

  • 1. HIV and hepatitis virus infections among injecting drug users in a medically controlled heroin prescription programme.
    Steffen T; Blättler R; Gutzwiller F; Zwahlen M
    Eur J Public Health; 2001 Dec; 11(4):425-30. PubMed ID: 11766485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infectious diseases and public health: risk-taking behavior during participation in the Swiss program for a medical prescription of narcotics (PROVE).
    Steffen T; Christen S; Blättler R; Gutzwiller F;
    Subst Use Misuse; 2001 Jan; 36(1-2):71-89. PubMed ID: 11305355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus infection: prevalence, predictor variables and prevention opportunities among drug users in Italy.
    Quaglio GL; Lugoboni F; Pajusco B; Sarti M; Talamini G; Mezzelani P; Des Jarlais DC;
    J Viral Hepat; 2003 Sep; 10(5):394-400. PubMed ID: 12969192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995.
    Broers B; Junet C; Bourquin M; Déglon JJ; Perrin L; Hirschel B
    AIDS; 1998 Oct; 12(15):2059-66. PubMed ID: 9814875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. History of syringe sharing in prison and risk of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection among injecting drug users in Berlin.
    Stark K; Bienzle U; Vonk R; Guggenmoos-Holzmann I
    Int J Epidemiol; 1997 Dec; 26(6):1359-66. PubMed ID: 9447418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rates of HIV and Hepatitis Infections in Clients Entering Heroin-Assisted Treatment between 2003 and 2013 and Risk Factors for Hepatitis C Infection.
    Dickson-Spillmann M; Haug S; Uchtenhagen A; Bruggmann P; Schaub MP
    Eur Addict Res; 2016; 22(4):181-91. PubMed ID: 26656112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of hepatitis and HIV infections and vaccination rates in patients entering the heroin-assisted treatment in Switzerland between 1994 and 2002.
    Gerlich M; Gschwend P; Uchtenhagen A; Krämer A; Rehm J
    Eur J Epidemiol; 2006; 21(7):545-9. PubMed ID: 16858622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy.
    Guadagnino V; Zimatore G; Izzi A; Caroleo B; Rocca A; Montesano F; Costa C; Masciari R; Naso E; Biselli R
    J Clin Lab Immunol; 1995; 47(1):1-9. PubMed ID: 8735431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High prevalence but low awareness of hepatitis C virus infection among heroin users who received methadone maintenance therapy in Taiwan.
    Ng MH; Chou JY; Chang TJ; Lee PC; Shao WC; Lin TY; Chen VC; Gossop M
    Addict Behav; 2013 Apr; 38(4):2089-93. PubMed ID: 23403277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study.
    Gschwend P; Rehm J; Blättler R; Steffen T; Seidenberg A; Christen S; Bürki C; Gutzwiller F
    Eur Addict Res; 2004; 10(1):41-8. PubMed ID: 14665805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, hepatitis B, human immunodeficiency, and human T-lymphotropic viruses.
    Garfein RS; Vlahov D; Galai N; Doherty MC; Nelson KE
    Am J Public Health; 1996 May; 86(5):655-61. PubMed ID: 8629715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in HIV, hepatitis B and hepatitis C prevalence among Australian prisoners - 2004, 2007, 2010.
    Reekie JM; Levy MH; Richards AH; Wake CJ; Siddall DA; Beasley HM; Kumar S; Butler TG
    Med J Aust; 2014 Mar; 200(5):277-80. PubMed ID: 24641153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in hepatitis B virus, hepatitis C virus, and human immunodeficiency virus prevalence, risk behaviors, and preventive measures among Seattle injection drug users aged 18-30 years, 1994-2004.
    Burt RD; Hagan H; Garfein RS; Sabin K; Weinbaum C; Thiede H
    J Urban Health; 2007 May; 84(3):436-54. PubMed ID: 17356901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral hepatitis and drugs: a continuing problem.
    Patti AM; Santi AL; Pompa MG; Giustini C; Vescia N; Mastroeni I; Fara GM
    Int J Epidemiol; 1993 Feb; 22(1):135-9. PubMed ID: 8449633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of changes to heroin supply on blood-borne virus notifications and injecting related harms in New South Wales, Australia.
    Day C; Degenhardt L; Gilmour S; Hall W
    BMC Public Health; 2005 Aug; 5():84. PubMed ID: 16102177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spread of bloodborne viruses among Australian prison entrants.
    Crofts N; Stewart T; Hearne P; Ping XY; Breshkin AM; Locarnini SA
    BMJ; 1995 Feb; 310(6975):285-8. PubMed ID: 7866168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High hepatitis C virus prevalence and incidence in a community cohort of young heroin injectors in a context of extensive harm reduction programmes.
    Vallejo F; Barrio G; Brugal MT; Pulido J; Toro C; Sordo L; Espelt A; Bravo MJ;
    J Epidemiol Community Health; 2015 Jun; 69(6):599-603. PubMed ID: 25870164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV, Hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India.
    Ray Saraswati L; Sarna A; Sebastian MP; Sharma V; Madan I; Thior I; Pulerwitz J; Tun W
    BMC Public Health; 2015 Jul; 15():726. PubMed ID: 26223866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early decline in an epidemic: evolution of the prevalences of HIV, hepatitis B, hepatitis C and aminotransferases in intravenous drug abusers in Strasbourg between 1980 and 1990].
    Will T
    Rev Med Suisse Romande; 1999 Apr; 119(4):329-34. PubMed ID: 10361471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
    Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
    Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.